Search
Evolution of genes and genomes on the Drosophila phylogeny.
Comparative analysis of multiple genomes in a phylogenetic framework dramatically improves the precision and sensitivity of evolutionary inference, producing more robust results than single-genome analyses can provide. The genomes of 12 Drosophila species, ten of which are presented here for the first time (sechellia, simulans, yakuba, erecta, ananassae, persimilis, willistoni, mojavensis, virilis and grimshawi), illustrate how rates and patterns of sequence divergence across taxa can...
Prepared Statement on the Supreme Court Human Gene Patent Ruling
FOR IMMEDIATE RELEASE—La Jolla, CA June 13, 2013 J. Craig Venter, Ph.D., Founder and CEO, Synthetic Genomics Inc. and Founder and CEO, the J. Craig Venter Institute “Today the United States Supreme Court ruled on the validity of BRAC1 and BRAC2 human gene patents stating that, ‘A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA is patent eligible because it is not naturally occurring,’ is consistent...
Emory School of Nursing faculty member receives research grant from The ALS Association
School of Nursing professor Vicki Hertzberg, PhD, FASA has received a three-year grant from The ALS Association to fund a study focusing on microbes in ALS patients. The study examines a small cohort of Amyotrophic Lateral Sclerosis (ALS) patients with their partner or caregiver as controls with respect to the microbes comprising their gut and oral microbiota, with baseline evaluation within six months of ALS diagnosis and again at three months and again at six months. The...
Synthetic Genomics, Inc. Launched to Develop New Approaches to Biological Energy
Rockville, MD – June 29, 2005 – Synthetic Genomics, Inc., a new company that will develop and commercialize synthetic biology, was launched today. The Company will engineer modular “cassette” based systems to execute specific functions using reprogrammed cells as bio-factories. Synthetic Genomics, Inc.’s initial focus will be on ethanol and hydrogen production. After leveraging enormous archives of genomic sequence data, the Company will integrate novel processes to design,...
GCID Outreach: Training the Next Generation of Genomic Scientists
The J. Craig Venter Institute (JCVI) Genomic Center for Infectious Diseases (GCID) was established by the National Institute of Allergy and Infectious Disease (NIAID) to explore disease biology through the application of nucleic acid sequencing and bioinformatics analysis tools. Throughout the history of the program, which is in its third iteration, GCID has been focused on expanding access to these technological platforms through education and outreach. To that end, we have devoted...
UCSD-TCAG Collaboration to Focus on Transformation of Genome-Based Knowledge Into Health Benefits
LA JOLLA, Ca., Sept. 25 (AScribe Newswire) -- The University of California, San Diego (UCSD) and The Center for the Advancement of Genomics (TCAG) in Rockville, Md., today announced a formal collaboration in genomic medicine that combines large-scale human genome analysis with innovative medical research. Through this new collaboration, the two organizations will conduct genomic studies aimed at elucidating the links between multi-gene associations and the prediction and outcome of disease,...
Research Team Publishes New Methods for Synthetic Generation of Influenza Vaccines
LA JOLLA, CA and ROCKVILLE, MD — May 15, 2013 — A team of international researchers from the J. Craig Venter Institute (JCVI), Synthetic Genomics Inc. (SGI), Novartis Vaccines and Diagnostics, the Biomedical Advanced Research and Development Authority (BARDA, US Department of Health and Human Services), and Institut fur Virologie, Universitat, has published a study detailing new methods to rapidly generate influenza vaccine seeds by using synthetic genomics tools and technologies. ...
1st Minimal Cell Workshop
View complete playlist for the workshop on YouTube. Day 1 — September 20, 2021 Time PDT Video Title Presenter Organization PI 5:00 - 5:15 Welcome and introduction John Glass 5:15 - 5:27 Restoring complete pyruvate hydrogenase gene to JCVI-syn3A increases growth rate as predicted by FBA whole cell computational model...
JCVI Research Impact
JCVI ranks in the top 1% of research institutions worldwide for research impact based on an analysis of Elsevier and Thomson Reuters data. The ranking was done by looking at institutional publication reach as seen through the number of citations referencing them. Institution Excellence Rate Broad Institute of MIT and Harvard 49.53 Whitehead Institute for Biomedical Research...
About John Glass
John Glass is a professor, leader of the JCVI Synthetic Biology Group, and La Jolla, CA Campus Director at the J. Craig Venter Institute. His expertise is in molecular biology, microbial pathogenesis, RNA virology, and microbial genomics. Dr. Glass is also an adjunct faculty member of the University of Maryland at College Park Cellular and Molecular Biology Program, and member of the Global Viral Network Scientific Leadership Board.